Efficacy and Safety of Phosphate-Lowering Agents for Adult Patients with CKD Requiring Dialysis: A Network Meta-Analysis. [PDF]
Nishimoto M +13 more
europepmc +1 more source
Parathyroidectomy in the treatment of uremic tumoral calcinosis: a 9-year case report and meta-analysis. [PDF]
Huang H +9 more
europepmc +1 more source
Risk factors for drug-related gastrointestinal ulcer:a retrospective pharmacovigilance study. [PDF]
Jiang S +8 more
europepmc +1 more source
Pill Burden: A Quality-of-Life Measure After Parathyroidectomy for Secondary Hyperparathyroidism. [PDF]
Acker RC +7 more
europepmc +1 more source
Hyperphosphatemia in Kidney Failure: Pathophysiology, Challenges, and Critical Role of Phosphorus Management. [PDF]
Raju S, Saxena R.
europepmc +1 more source
Allopurinol has no effect on calcitriol or other CKD-MBD biomarkers: a randomized double-blind study. [PDF]
Costa TE +7 more
europepmc +1 more source
Biomimetic wrinkled prebiotic microspheres with enhanced intestinal retention for hyperphosphatemia and vascular calcification. [PDF]
Hu B +8 more
europepmc +1 more source
The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial. [PDF]
Pluquet M +7 more
europepmc +1 more source
Decoding vascular calcification: mechanistic insights and translational strategies. [PDF]
Adelnia H, Ray S, Ta HT.
europepmc +1 more source
Efficacy of tenapanor in managing hyperphosphatemia and constipation in hemodialysis patients: A randomized controlled trial. [PDF]
Suzuki N +12 more
europepmc +1 more source

